Element Nutritional Sciences Provides Operational Milestone Review and 2023 Outlook
Element Nutritional Sciences Inc. (OTC:ELNSF) provides a 2022 operational review and 2023 outlook, highlighting its brands, Rejuvenate™ and Promino™. The U.S. functional beverage market is valued at over
- Revenue increased over 100% year-over-year in Q3 2022, reaching $4.1 million.
- Gross margins improved to 23%.
- Established 33,000 distribution points in the U.S. and Canada.
- Launch of Rejuvenate™ ready-to-drink beverage expected in Q2 2023, benefiting from regulatory changes.
- Promino™ products are being introduced to major professional sports leagues, enhancing brand visibility.
- None.
Message from
The commercial opportunity for Element and its Rejuvenate™ and Promino™ brands remain as attractive as ever. In the
Element’s strategy continues to focus on driving sales by developing innovative products that improve muscle health. We have already started to realize results from our rebranding and improved product formulation as demonstrated by recent purchase orders from
Looking forward to 2023, regulatory changes from
The sports nutrition market is expected to drive incremental growth for Element in 2023. Our proprietary sports nutrition brand, Promino™, is the first patented NSF Certified for Sport® supplement to be made available to major sport leagues. Through a strategic partnership with
With the current changes to demographics and the continued demand for functional beverages are expected to provide tailwinds as we build revenue for our suite of innovative and patented brands. With a new formulation, changes in product mix, rigorous cost discipline and growing sales, we also believe we can improve profitability as we scale. In Q4 2022, we completed significant consumer insight work with our new ready-to-drink brand. We have positive consumer acceptance across the board in all areas including flavor, packaging, concept and price. This work is expected to translate into retail acceptance and consumer demand.
I would like to personally thank all our investors for their support. In 2022, we made significant progress towards unlocking our potential and improving muscle health for global consumers. We believe our team is well equipped to maintain our momentum into 2023 by breaking into new distribution channels with brands that are among the most innovative muscle health products in the nutritional market and that can lead the way to help millions of people improve their overall health and well being.
Key Milestones in 2022
Distribution
-
Received purchase orders from
Shoppers Drug Mart Inc. ("Shoppers") to distribute Rejuvenate™ Muscle Activator stick-packs across 594 Shoppers locations inCanada -
Announced Rejuvenate™ Muscle Activator ready-to-drink beverage is scheduled to launch in
Canada ahead of schedule, followingHealth Canada regulatory changes, with expected Canadian retail launch in 2023 Q2. -
Entered into a contract with Dr.
James LaValle andMike Potenza to promote and educate professional sports leagues and teams on the benefits of Promino™, Element’s proprietary sports nutrition brand -
Announced that Rejuvenate™
Immune Health is available to consumers on the Amazon platform in theU.S. through a distribution partnership with e-commerce acceleratorPattern Inc. -
Signed a distribution agreement with
OCSB Emerging Brands Group (“OCS Brands”), whereby OCS Brands will distribute Rejuvenate™ across the convenience services channel in theU.S. - Rejuvenate™ products became available online at Walgreens.
- Integrated its JAKTRX™ performance supplement branded products on Amazon.com
- Announced that its new and patented Promino™ line of sports nutrition products became available on Amazon with sales and fulfillment facilitated through Pattern
Innovation
- Completed commercialization for Clinical Strength Rejuvenate™ targeted towards the medical practitioner market
- Acquired the right to use the same plant-based amino acid formulation underlying its Rejuvenate™ muscle health products to develop a new higher dosage formulation for the sports nutrition market
-
Announced that the clinically proven amino acid formulation used in Rejuvenate™ received a global Patent Cooperation Treaty patent issued by the
U.S. Patent and Trademark Office
Financial and Corporate
-
Generated revenue of
for the year-to-date Q3 2022, a$4.1 million 100% increase over the same period in the prior year, with a gross margin of23% -
Commenced trading on the OTCQB® Venture Market (OTCQB) under the symbol “ELNSF” on
February 2, 2022
About Element
Element is an innovative and research driven Canadian nutraceutical company specializing in the development of patented and science-based products for the global consumer packaged goods market, with a portfolio focused specifically on men and women over the age of 40. Element’s lead product, Rejuvenate™, is a proprietary formulation that is clinically proven to assist in the rebuilding, restoration and rejuvenation of natural loss of muscle mass due to aging or other medical conditions. Element also offers JAKTRX™, an elite brand of performance supplements. Element was founded in 2015 and is located in
To learn more about Element, visit elmtinc.com.
More information about Rejuvenate™ can be found at: www.rejuvenatemuscle.com
More information about JAKTRX™ and Promino™ can be found at: www.jaktrx.com
Forward Looking Statements
This news release contains "forward-looking information" and "forward-looking statements" (collectively, "forward looking statements") within the meaning of the applicable Canadian securities legislation. All statements, other than statements of historical fact, are forward-looking statements and are based on expectations, estimates and projections as at the date of this news release. Any statement that involves discussions with respect to predictions, expectations, beliefs, plans, projections, objectives, assumptions, future events or performance (often but not always using phrases such as “expects”, or “does not expect”, “is expected”, “anticipates” or “does not anticipate”, “plans”, “budget”, “scheduled”, “forecasts”, “estimates”, “believes” or “intends” or variations of such words and phrases or stating that certain actions, events or results “may” or “could”, “would”, “might” or “will” be taken to occur or be achieved) are not statements of historical fact and may be forward-looking statements. Forward looking statements in this news release include: the expected growth in the functional beverage market, the expected launch of Rejuvenate™ ready-to-drink beverage in
These forward-looking statements are based on reasonable assumptions and estimates of management of the Company at the time such statements were made. Actual future results may differ materially as forward-looking statements involve known and unknown risks, uncertainties and other factors which may cause the actual results, performance or achievements of the Company to materially differ from any future results, performance or achievements expressed or implied by such forward-looking statements. Such factors, among other things, include: fluctuations in general macroeconomic conditions; expectations regarding the size of
No stock exchange, securities commission or other regulatory authority has approved or disapproved the information contained herein.
1 Euromonitor,
2 Mintels US Functional Drinks Market Report 2021.
View source version on businesswire.com: https://www.businesswire.com/news/home/20230111005157/en/
For further information:
Chairman, CEO and President
ir@elementnutrition.com
416-467-5229
Investor Relations
ir@elementnutrition.com
416-467-5229
Source:
FAQ
What are the key operational milestones for Element Nutritional Sciences Inc. in 2022?
How much revenue did Element Nutritional Sciences report for Q3 2022?
What is the expected impact of regulatory changes in Canada on Element's products?
What growth strategy is Element Nutritional Sciences pursuing in 2023?